
    
      This is a single-center, randomized study to compare the diagnostic performance and safety of
      ascending doses (0.10 mg/cm², 0.20 mg/cm² and 0.40 mg/cm²) of hydroxyisohexyl 3-cyclohexene
      carboxaldehyde (Lyral®) in 20 adult subjects with a past positive patch test to Lyral® or
      Fragrance Mix 2.
    
  